Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yekaterina Krutsenko

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Biochemical Pharmacology|February 11, 2021
Higher susceptibility to heme oxidation and lower protein stability of the rare α<sub>1</sub>C517Yβ<sub>1</sub> sGC variant associated with moyamoya syndromeIraida Sharina, Karina Lezgyieva, Yekaterina Krutsenko, et al.
Cancers|April 30, 2021
β-Catenin Activation in Hepatocellular Cancer: Implications in Biology and TherapyYekaterina Krutsenko, Aatur D Singhi, Satdarshan P Monga
The American Journal of Pathology|November 6, 2022
Inhibition of Heat Shock Factor 1 Signaling Decreases Hepatoblastoma Growth via Induction of ApoptosisEdward H Hurley, Junyan Tao, Silvia Liu, et al.
Hepatology Communications|August 9, 2023
Loss of TAZ after YAP deletion severely impairs foregut development and worsens cholestatic hepatocellular injuryAdelya Gabdulkhakova, Yekaterina Krutsenko, Junjie Zhu, et al.
STAR Protocols|March 4, 2022
LiverClear: A versatile protocol for mouse liver tissue clearingLaura M Molina, Yekaterina Krutsenko, Nathaniel E C Jenkins, et al.
Hepatology (Baltimore, Md.)|February 2, 2021
Nuclear factor erythroid 2-related factor 2 and β-Catenin Coactivation in Hepatocellular Cancer: Biological and Therapeutic ImplicationsJunyan Tao, Yekaterina Krutsenko, Akshata Moghe, et al.
Hepatology (Baltimore, Md.)|October 23, 2025
Glutamine synthetase loss in β-catenin-mutant hepatocellular carcinoma promotes tumor burden through macrophage metabolic reprogrammingEvan R Delgado, Panari Patel, Junyan Tao, et al.
British Journal of Pharmacology|May 1, 2021
Involvement of 3',5'-cyclic inosine monophosphate in cystathionine γ-lyase-dependent regulation of the vascular toneEmma Mitidieri, Valentina Vellecco, Vincenzo Brancaleone, et al.
Cell Reports|July 7, 2021
Compensatory hepatic adaptation accompanies permanent absence of intrahepatic biliary network due to YAP1 loss in liver progenitorsLaura M Molina, Junjie Zhu, Qin Li, et al.
Research Square|December 23, 2024
Precision targeting of β-catenin induces tumor reprogramming and immunity in hepatocellular cancersBrandon M Lehrich, Evan R Delgado, Tyler M Yasaka, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Biochemical Pharmacology|February 11, 2021
Higher susceptibility to heme oxidation and lower protein stability of the rare α<sub>1</sub>C517Yβ<sub>1</sub> sGC variant associated with moyamoya syndromeIraida Sharina, Karina Lezgyieva, Yekaterina Krutsenko, et al.
Cancers|April 30, 2021
β-Catenin Activation in Hepatocellular Cancer: Implications in Biology and TherapyYekaterina Krutsenko, Aatur D Singhi, Satdarshan P Monga
The American Journal of Pathology|November 6, 2022
Inhibition of Heat Shock Factor 1 Signaling Decreases Hepatoblastoma Growth via Induction of ApoptosisEdward H Hurley, Junyan Tao, Silvia Liu, et al.
Hepatology Communications|August 9, 2023
Loss of TAZ after YAP deletion severely impairs foregut development and worsens cholestatic hepatocellular injuryAdelya Gabdulkhakova, Yekaterina Krutsenko, Junjie Zhu, et al.
STAR Protocols|March 4, 2022
LiverClear: A versatile protocol for mouse liver tissue clearingLaura M Molina, Yekaterina Krutsenko, Nathaniel E C Jenkins, et al.
Hepatology (Baltimore, Md.)|February 2, 2021
Nuclear factor erythroid 2-related factor 2 and β-Catenin Coactivation in Hepatocellular Cancer: Biological and Therapeutic ImplicationsJunyan Tao, Yekaterina Krutsenko, Akshata Moghe, et al.
Hepatology (Baltimore, Md.)|October 23, 2025
Glutamine synthetase loss in β-catenin-mutant hepatocellular carcinoma promotes tumor burden through macrophage metabolic reprogrammingEvan R Delgado, Panari Patel, Junyan Tao, et al.
British Journal of Pharmacology|May 1, 2021
Involvement of 3',5'-cyclic inosine monophosphate in cystathionine γ-lyase-dependent regulation of the vascular toneEmma Mitidieri, Valentina Vellecco, Vincenzo Brancaleone, et al.
Cell Reports|July 7, 2021
Compensatory hepatic adaptation accompanies permanent absence of intrahepatic biliary network due to YAP1 loss in liver progenitorsLaura M Molina, Junjie Zhu, Qin Li, et al.
Research Square|December 23, 2024
Precision targeting of β-catenin induces tumor reprogramming and immunity in hepatocellular cancersBrandon M Lehrich, Evan R Delgado, Tyler M Yasaka, et al.
Pageof 1